HealthEquity (NASDAQ:HQY) Hits New 12-Month High - Still a Buy?

HealthEquity, Inc. (NASDAQ:HQY - Get Free Report)'s share price hit a new 52-week high during mid-day trading on Monday . The company traded as high as $112.53 and last traded at $110.38, with a volume of 79028 shares traded. The stock had previously closed at $110.42.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on HQY shares. Bank of America upped their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a research note on Wednesday, November 13th. The Goldman Sachs Group began coverage on HealthEquity in a report on Friday, November 15th. They issued a "neutral" rating and a $108.00 price objective for the company. Mizuho began coverage on HealthEquity in a report on Wednesday, December 4th. They set an "outperform" rating and a $126.00 target price for the company. JMP Securities lifted their price target on shares of HealthEquity from $105.00 to $107.00 and gave the company a "market outperform" rating in a report on Tuesday, December 10th. Finally, BTIG Research upped their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a report on Thursday, November 14th. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $110.71.

HealthEquity Stock Performance

The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The stock has a market capitalization of $9.71 billion, a P/E ratio of 102.80, a PEG ratio of 1.94 and a beta of 0.55. The business has a 50-day moving average price of $100.58 and a 200 day moving average price of $89.18.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period in the prior year, the company earned $0.40 earnings per share. As a group, sell-side analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $101.56, for a total value of $837,870.00. Following the completion of the sale, the director now directly owns 66,469 shares in the company, valued at $6,750,591.64. The trade was a 11.04 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the transaction, the director now owns 19,061 shares in the company, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company's stock.

Hedge Funds Weigh In On HealthEquity

Several hedge funds and other institutional investors have recently modified their holdings of HQY. Holocene Advisors LP bought a new position in HealthEquity in the third quarter valued at about $1,246,000. GSA Capital Partners LLP purchased a new stake in shares of HealthEquity during the 3rd quarter valued at about $638,000. Natixis Advisors LLC lifted its stake in shares of HealthEquity by 29.8% in the 3rd quarter. Natixis Advisors LLC now owns 209,175 shares of the company's stock worth $17,122,000 after purchasing an additional 48,009 shares during the period. Vaughan Nelson Investment Management L.P. boosted its holdings in shares of HealthEquity by 36.7% in the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company's stock worth $69,034,000 after buying an additional 226,563 shares during the last quarter. Finally, Loomis Sayles & Co. L P grew its position in HealthEquity by 2.2% during the third quarter. Loomis Sayles & Co. L P now owns 1,126,645 shares of the company's stock valued at $92,216,000 after buying an additional 24,665 shares during the period. 99.55% of the stock is owned by institutional investors.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.